Atlas Trials

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Clinical trial NCT05859997 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05859997
Sponsor
Bioray Laboratories
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic SclerosisInflammatory MyopathyANCA Associated Systemic VasculitisAntiphospholipid Syndrome
Start date
2023-05-17
Primary completion
2024-05-27
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.